T2 Biosystems Inc (NASDAQ:TTOO)’s traded shares stood at 4.04 million during the last session, with the company’s beta value hitting 0.31. At the close of trading, the stock’s price was $1.44, to imply a decrease of -6.49% or -$0.1 in intraday trading. The TTOO share’s 52-week high remains $8.38, putting it -481.94% down since that peak but still an impressive 6.94% since price per share fell to its 52-week low of $1.34. The company has a valuation of $25.17M, with an average of 0.77 million shares in intraday trading volume over the past 10 days and average of 244.89K shares over the past 3 months.
T2 Biosystems Inc (NASDAQ:TTOO) trade information
After registering a -6.49% downside in the last session, T2 Biosystems Inc (TTOO) has traded red over the past five days. The 5-day price performance for the stock is 2.86%, and -29.76% over 30 days. With these gigs, the year-to-date price performance is -77.05%. Short interest in T2 Biosystems Inc (NASDAQ:TTOO) saw shorts transact 0.36 million shares and set a 1.73 days time to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The extremes give us $5 and $5 for target low and target high price respectively. As such, TTOO has been trading -247.22% off suggested target high and -247.22% from its likely low.
T2 Biosystems Inc (TTOO) estimates and forecasts
Revenue is forecast to grow 92.00% this quarter before jumping 85.80% for the next one. The rating firms project that company’s revenue will grow 47.40% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is 2.8M. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 3.7M.Earnings reports from the last fiscal year show that sales brought in 1.47M and 1.68M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 90.20% before jumping 120.40% in the following quarter.
TTOO Dividends
T2 Biosystems Inc has its next earnings report out in November. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
T2 Biosystems Inc (NASDAQ:TTOO)’s Major holders
T2 Biosystems Inc insiders hold 4.45% of total outstanding shares, with institutional holders owning 74.65% of the shares at 78.12% float percentage. In total, 74.65% institutions holds shares in the company.
